Literature DB >> 4040189

Kinetics of cellular proliferation after arterial injury. II. Inhibition of smooth muscle growth by heparin.

A W Clowes, M M Clowes.   

Abstract

Heparin inhibits intimal thickening after arterial injury. Whether this effect is due to inhibition of medial smooth muscle cell (SMC) migration, SMC proliferation in the intima, or synthesis and deposition of connective tissue has not been evident. In this study we have investigated these possibilities in a rat carotid balloon injury model. Heparin (0.3 mg/kg/hour) was administered intravenously by means of osmotic pumps to experimental animals, and controls received lactated Ringer's solution. Smooth muscle proliferation (thymidine index), intimal smooth muscle accumulation, and endothelial regeneration were measured at intervals between 0 and 28 days. Total smooth muscle growth as determined biochemically at 14 days was markedly inhibited by heparin if the pumps were placed 24 hours before or at the time of injury and less so if inserted 48 or 96 hours after injury. SMC thymidine indices were maximal in the media at 4 days and in the intima at 7 days for injured arteries of both heparin-treated and control rats; at each time point SMC proliferation and intimal thickening were less in heparin-treated rats. The volume of connective tissue in the intima was the same in both groups at 28 days. Medial SMC migration into the intima was diminished by heparin treatment, but endothelial regeneration was not affected. These results support the hypothesis that heparin is a specific inhibitor of SMC migration and proliferation and is most effective if started before SMC enter S-phase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040189

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  37 in total

1.  Tissue concentration of heparin, not administered dose, correlates with the biological response of injured arteries in vivo.

Authors:  M A Lovich; E R Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

2.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

3.  Heparin/endothelial cell growth supplement regulates matrix gene expression and prolongs life span of vascular smooth muscle cells through modulation of interleukin-1.

Authors:  J Y Hsu; M Y Hsu; T Sorger; M Herlyn; E M Levine
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

Review 4.  In stent restenosis: bane of the stent era.

Authors:  A K Mitra; D K Agrawal
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 5.  Cell culture systems to study progression and inhibition of intimal proliferations.

Authors:  E Betz
Journal:  Basic Res Cardiol       Date:  1991 Mar-Apr       Impact factor: 17.165

6.  Inhibition of vein graft intimal proliferative lesions in the rat by heparin.

Authors:  G M Hirsch; M J Karnovsky
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

7.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

8.  Rat carotid artery balloon injury model.

Authors:  David A Tulis
Journal:  Methods Mol Med       Date:  2007

9.  Smooth muscle cell expression of extracellular matrix genes after arterial injury.

Authors:  S T Nikkari; H T Järveläinen; T N Wight; M Ferguson; A W Clowes
Journal:  Am J Pathol       Date:  1994-06       Impact factor: 4.307

10.  Proliferating cell nuclear antigen immunohistochemistry in rat aorta after balloon denudation. Comparison with thymidine and bromodeoxyuridine labeling.

Authors:  U Zeymer; M C Fishbein; J S Forrester; B Cercek
Journal:  Am J Pathol       Date:  1992-09       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.